Last reviewed · How we verify

COVID-19 Vaccine 1

ModernaTX, Inc. · Phase 1 active Biologic

COVID-19 Vaccine 1 is a Biologic drug developed by ModernaTX, Inc.. It is currently in Phase 1 development.

At a glance

Generic nameCOVID-19 Vaccine 1
SponsorModernaTX, Inc.
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about COVID-19 Vaccine 1

What is COVID-19 Vaccine 1?

COVID-19 Vaccine 1 is a Biologic drug developed by ModernaTX, Inc..

Who makes COVID-19 Vaccine 1?

COVID-19 Vaccine 1 is developed by ModernaTX, Inc. (see full ModernaTX, Inc. pipeline at /company/modernatx-inc).

What development phase is COVID-19 Vaccine 1 in?

COVID-19 Vaccine 1 is in Phase 1.

Related